ABTI - ALTEROLA BIOTECH INC.
0.0051
0.000 1.961%
Share volume: 10,000
Last Updated: 02-23-2026
Pharmaceutical Products/Medicinal Chemicals:
-0.08%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.02%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 11-25-2024 | 11-21-2023 | 11-28-2024 | 11-25-2024 | 11-28-2024 | |
| Assets | ||||||
| Total Assets | 12.693 M | 497.208 K | 3.663 K | 975.225 K | 1.364 M | |
| Current Assets | 231.207 K | 197.208 K | 3.663 K | 715.274 K | 1.147 M | |
| Inventories | 1.009 K | 975.000 | 1.009 K | 1.011 K | 1.069 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 36.545 K | 9.102 K | 2.654 K | 714.263 K | 82.720 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 12.462 M | 300.000 K | 0.000 | 259.951 K | 217.045 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 12.693 M | 497.208 K | 3.663 K | 975.225 K | 1.364 M | |
| Total liabilities | 2.334 M | 2.519 M | 1.333 M | 2.440 M | 3.615 M | |
| Total current liabilities | 2.334 M | 2.519 M | 1.333 M | 2.440 M | 3.615 M | |
| Accounts Payable | 677.988 K | 722.124 K | 825.210 K | 868.248 K | 805.308 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 10.359 M | -2.080 M | -1.330 M | -1.376 M | -2.055 M | |
| Common stock | 20.664 M | 8.359 M | 11.047 M | 11.570 M | 11.694 M | |
| Retained earnings | -10.295 M | -10.431 M | -12.416 M | -12.982 M | -13.674 M |